FDA Inspection 1103220 - Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy - September 27, 2019
FDA Inspection 1103220 for Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy on September 27, 2019. Classification: Voluntary Action Indicated (VAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1103220 for Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy on September 27, 2019. Classification: Voluntary Action Indicated (VAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
September 27, 2019
Product Type
Drugs
ID: 8b5d395e-cc9f-4e05-afd3-225c4c7ea673
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox